Recent Quarter Total Invested
$2.57 B
Recent Quarter Institutional Ownership Percentage
101.73%
Total Invested of Last Quarter
$2.41 B
Ownership Percentage of Last Quarter
98.38%
Agios Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 5.66 M | $251.51 M | 0.11% | 9.94% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.02 M | $223.12 M | 100.00% | 8.82% |
| BELLEVUE GROUP AG | 11/14/2024 | 3.74 M | $165.99 M | -3.70% | 6.56% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.83 M | $125.85 M | 1.99% | 4.97% |
| STATE STREET CORP | 11/14/2024 | 2.33 M | $103.59 M | 10.24% | 4.09% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.21 M | $98.06 M | 6.15% | 3.88% |
| 11/14/2024 | 2.18 M | $97.20 B | 100.00% | 3.84% | |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.71 M | $76.11 M | -3.56% | 3.01% |
| MACQUARIE GROUP LTD | 11/14/2024 | 1.69 M | $75.12 M | -2.25% | 2.97% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.56 M | $69.41 M | -28.87% | 2.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.36 M | $60.33 M | 0.45% | 2.38% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.26 M | $56.13 M | 11.43% | 2.22% |
| BVF INC/IL | 11/14/2024 | 1.19 M | $52.88 M | 0.00% | 2.09% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 1.04 M | $46.39 M | 19.75% | 1.83% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.00 M | $44.52 M | 100.00% | 1.76% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 907,044 | $40.30 M | -0.45% | 1.59% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 882,731 | $39.22 M | -13.40% | 1.55% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 855,328 | $38.00 M | 20.48% | 1.50% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 760,000 | $33.77 M | 100.00% | 1.33% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 699,389 | $31.07 M | -33.03% | 1.23% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/07/2024 | 630,946 | $28.03 M | 6.03% | 1.11% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 612,366 | $27.21 M | 36.43% | 1.08% |
| CALIGAN PARTNERS LP | 11/14/2024 | 579,717 | $25.76 M | 12.63% | 1.02% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 532,404 | $23.65 M | -21.50% | 0.94% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 476,657 | $21.18 M | -13.18% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 465,620 | $20.69 M | 1.77% | 0.82% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 400,849 | $18.28 M | -5.02% | 0.70% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 391,842 | $17.41 M | 22.27% | 0.69% |
| MORGAN STANLEY | 11/14/2024 | 348,973 | $15.50 M | -41.51% | 0.61% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 333,075 | $14.80 M | 1.93% | 0.59% |
| EAGLE HEALTH INVESTMENTS LP | 11/12/2024 | 330,830 | $14.70 M | 0.00% | 0.58% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 300,000 | $13.33 M | 990.91% | 0.53% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 285,099 | $12.67 M | -36.14% | 0.50% |
| CANDRIAM S.C.A. | 11/13/2024 | 261,505 | $11.62 M | -19.01% | 0.46% |
| AXA S.A. | 11/14/2024 | 238,750 | $10.61 M | 0.03% | 0.42% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 233,056 | $10.35 M | 4.05% | 0.41% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 227,272 | $10.37 M | 7.98% | 0.40% |
| NORDEA INVESTMENT MANAGEMENT AB | 11/05/2024 | 212,976 | $9.71 M | -5.28% | 0.37% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 196,399 | $8.73 M | -38.73% | 0.34% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 186,623 | $8.29 M | 100.00% | 0.33% |
| BARCLAYS PLC | 11/19/2024 | 180,417 | $8.02 M | 64.19% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 178,425 | $7.93 M | -20.04% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 162,741 | $7.23 M | -48.81% | 0.29% |
| CENTERBOOK PARTNERS LP | 11/14/2024 | 154,088 | $6.85 M | -38.19% | 0.27% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 150,785 | $6.70 M | 10.19% | 0.26% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 150,000 | $6.66 M | 100.00% | 0.26% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 144,020 | $6.40 M | 623.36% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 143,431 | $6.37 M | 4.05% | 0.25% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 138,142 | $6.14 M | 316.54% | 0.24% |
| INVESCO LTD. | 11/12/2024 | 118,947 | $5.28 M | 0.79% | 0.21% |
Agios Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of AGIO shares?
During the previous two years, 284 institutional investors and hedge funds held shares of Agios Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FARALLON CAPITAL MANAGEMENT LLC: 5.66 M
BlackRock Funding, Inc. /DE: 5.02 M
Bellevue Group AG: 3.74 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.83 M
STATE STREET CORP: 2.33 M
ARMISTICE CAPITAL, LLC: 2.21 M
-
What percentage of Agios Pharmaceuticals, Inc. stock is owned by institutional investors?
101.73% of Agios Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at AGIO ?
Institutional investors have bought a total of 67.03 M shares in the last 24 months. This purchase volume represents approximately $3.74 B in transactions.